Jiva Ayurveda launches first-ever diagnostic protocols for Ayurveda

IMT News Desk
IMT News Desk
· 3 min read
AYUSH Secretary, Vaidya Rajesh Kotecha
AYUSH Secretary, Vaidya Rajesh Kotecha officially launching the Jiva Ayunique™ Protocol and Jiva Health App

Jiva Ayurveda launched first-of-its-kind diagnostic protocols for Ayurveda in the presence of Vaidya Rajesh Kotecha, Secretary, Ministry of AYUSH, Govt. of India, with the aim to create a definite structure for this ancient healing tradition and turn it into globally accepted medical science.

Called Ayunique, the newly developed protocols are the result of a huge data analytics project that was initiated by Jiva Ayurveda six years ago. Using Big Data analytics and machine-learning techniques, the 5,000-year-old knowledge of Ayurveda and personalized treatment records of lakhs of patients at Jiva have been consolidated to offer the most advanced decision-support system for Ayurveda doctors. This will assist them in making root-cause based diagnosis in a structured, standardized and data-driven manner while allowing for the personalization of treatment.

Said Vaidya Rajesh Kotecha, Secretary, Ministry of AYUSH, Govt. of India: “On behalf of the Government, I congratulate Jiva Ayurveda for coming out with diagnostic protocols for Ayurveda, which is truly a unique achievement. Most practitioners of traditional systems of medicine are not able to communicate effectively with modern science. This science belongs to all humanity and we should not hesitate to deploy it for the advancement and validation of Indian healing systems. Jiva is a prime example of entrepreneurship which is using science to further the cause and acceptability of Ayurveda. AYUSH systems of medicine need a digital platform and IT-based solutions, and the diagnostic protocols by Jiva are a welcome step in this direction.”

Said Dr. Partap Chauhan, Director, Jiva Ayurveda: “Ayurveda is fundamentally a personalized system of medicine that aptly addresses the world’s challenge of moving away from a symptomatic-only approach to medicine. The Jiva Ayunique protocols are like the operating system for Ayurveda practice that structure the practice of Ayurveda and creates a wealth of data. They will truly enable a scientific approach in providing a more precise, personalized Ayurveda and establishing it as a globally accepted treatment science.”

Added Rishi Pal Chauhan, President, Jiva Group: “Ayurveda practitioners around the world are referred to as health and wellness coaches because Ayurveda is not recognized as medical science. Jiva Ayunique is a concrete step towards changing this status quo. The dream of ‘health for all’ can only be achieved if Ayurveda is made widely available throughout the world. However, for that to happen, acceptance of the science behind Ayurveda is a must.”

Jiva Ayunique Protocols have already been validated on more than 25,000 patients. Jiva is also collaborating with number of universities and institutes worldwide to undertake further research studies based on these.

The Jiva Health App was also launched. It provides authentic and actionable Ayurvedic health and wellness information through a personalized feed. The content is curated by the world-renowned Ayurvedacharya Dr. Partap Chauhan. At the core of the app is a recommendation-engine powered by artificial intelligence, which, based on user’s consumption patterns and preferences, serves them with a personalized stream of content.

Users can take number of Ayurvedic tests and health assessments. The app allows patients to connect with Jiva doctors for personalized consultation and treatment. They can also track their treatment history and access their records. The App is available on Google Play Store and Apple Store.

Read Next

Akums Reports Strong Q4 FY26 Performance; EBITDA Surges 62%, Board Recommends Dividend
News
May 15, 2026

Akums Reports Strong Q4 FY26 Performance; EBITDA Surges 62%, Board Recommends Dividend

Akums Drugs & Pharmaceuticals Ltd., India’s largest Contract Development and Manufacturing Organisation (CDMO), has reported a robust financial performance for the fourth quarter and full year ended March 31, 2026, driven by strong growth in its core CDMO business and improved operational efficiencies. Q4 FY26: Profitability Outpaces Revenue Growth Akums posted an operating revenue of […]
Article by: IMT News Desk
Alembic Pharmaceuticals announces USFDA Tentative Approval for Darolutamide Tablets
News
May 14, 2026

Alembic Pharmaceuticals announces USFDA Tentative Approval for Darolutamide Tablets

Alembic Pharmaceuticals Limited (Alembic) has received tentative approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Darolutamide Tablets, 300 mg. The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Nubeqa Tablets, 300 mg, of Bayer HealthCare Pharmaceuticals Inc. (Bayer). Darolutamide is an androgen […]
Article by: IMT News Desk
Lilly launches Lormalzi® (Donanemab) for the treatment of early symptomatic Alzheimer’s Disease in India
News
May 14, 2026

Lilly launches Lormalzi® (Donanemab) for the treatment of early symptomatic Alzheimer’s Disease in India

Eli Lilly and Company (India) Pvt. Ltd. has announced the launch of Lormalzi® (donanemab, 350 mg/20 mL IV vial) in India, following marketing authorisation from the Central Drugs Standard Control Organization (CDSCO) for the treatment of Alzheimer’s disease with mild cognitive impairment or those in the mild dementia stage of disease. Lormalzi® is the first […]
Article by: IMT News Desk
Stryker and Max Smart Hospital, Saket Partner to Advance Surgeon Training and Education in Robotic-Arm Assisted Joint Replacement
News
May 14, 2026

Stryker and Max Smart Hospital, Saket Partner to Advance Surgeon Training and Education in Robotic-Arm Assisted Joint Replacement

Stryker and Max Smart Super Speciality Hospital, Saket, announced a strategic collaboration to advance surgeon training, clinical education, and patient care in robotic-arm-assisted joint replacement in India. As part of this collaboration, Max Smart Super Speciality Hospital, Saket, will serve as a training and education center for orthopaedics. The collaboration aims to support the evolving joint replacement ecosystem […]
Article by: IMT News Desk